Thoratec, HeartWare to respond to FTC's second request

By Lisa Kerner

Charlotte, N.C., March 26 - The Federal Trade Commission asked for additional information from Thoratec Corp. and HeartWare International, Inc. regarding the companies' proposed merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

Thoratec and HeartWare said they are gathering information in response to the second request and expect to close the transaction in the second half of 2009.

In February, Thoratec announced it agreed to acquire HeartWare in a cash-and-stock deal valued at $282 million. Each share of HeartWare common stock will be converted into the right to receive $14.30 in cash and 0.6054 of a share of Thoratec common stock.

Thoratec, based in Pleasanton, Calif., develops, manufactures and markets proprietary medical devices used for circulatory support.

HeartWare is a medical device company located in Framingham, Mass., and Sydney, Australia.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.